Chile · Delayed Price · Currency is CLP Empresas CMPC Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw stable sales and EBITDA, but net income declined due to lower forest valuations and higher costs from mill maintenance. Leverage remains elevated but is expected to improve, with asset monetization and operational efficiencies supporting future performance.
Fiscal Year 2025
-
Fourth quarter 2025 saw higher sales and net income, with pulp driving growth and Softys maintaining margins despite tough competition. Biopackaging struggled with weak demand, while strategic asset sales and port investments support future projects.
-
Sales and profitability declined year-over-year due to lower pulp prices and increased competition, but management expects margin recovery as pulp prices rebound and cost initiatives take effect. Liquidity is being enhanced through hybrid bonds and potential asset monetization.
-
Q2 2025 saw sales of $1.9B, EBITDA of $332M, and net income of $81M, with sequential EBITDA growth but year-over-year declines due to lower prices. Major restructuring, a $74M non-recurring gain, and continued deleveraging efforts were key highlights.
-
First quarter 2025 saw $1.8B in sales, $278M EBITDA, and $50M net income, with Pulp leading segment results. Softis and biopackaging faced margin and demand pressures, but cost efficiencies and asset sales supported cash flow and deleveraging.
Fiscal Year 2024
-
Q4 2024 saw a sharp drop in EBITDA and net income due to lower pulp prices and currency headwinds, despite higher pulp volumes and ongoing cost initiatives. Management expects gradual margin recovery, with CapEx focused on forestry and maintenance, and a stable dividend policy.
-
3Q 2024 saw strong EBITDA and net income growth, led by the Pulp segment, while Softys faced headwinds from FX and lower demand. Net debt to EBITDA improved, and significant projects and acquisitions were highlighted. Overcapacity and market volatility remain key risks.
-
The company is advancing its 2030 strategy with a strong focus on sustainability, operational excellence, and innovation, highlighted by the $4.5 billion Natureza project and Softys’ leadership in Latin America. Cost reductions, digital transformation, and a robust pipeline of growth initiatives underpin its competitive positioning.
-
Q2 2024 saw sales of $1.888B, EBITDA of $377M, and net income of $125M, with pulp margins rising on higher prices and lower costs, while Softys and Biopackaging faced margin pressure from competition and currency effects. Net debt to EBITDA improved to 3.75x, and CapEx remains conservative ahead of the Natureza Project.